I

    InnovAge Holding Corp (INNV)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $10.80
    -0.06 (-0.55%)

    Market Cap: $1.47B

    Last updated: Sep 01, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    48%(12/25)
    Avg Surprise
    +7.99%
    Streak
    6 Q

    Upcoming Estimates

    Period ending Jun 30, 2026
    EPS Consensus$0.23
    Range$0.23 - $0.23
    1 analysts
    Revenue Consensus
    $274M
    Range$269M - $282M
    3 analysts
    Period ending Sep 30, 2026
    EPS Consensus$0.10
    Range$0.10 - $0.10
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate Drift
    90d ago$0.09-10.0%
    60d ago$0.09-10.0%
    30d ago$0.00-100.0%
    7d ago$0.00-100.0%
    Current$0.10
    Revenue Consensus
    $253M
    Range$248M - $257M
    2 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Sep 26EST
    		-$0.10---
    Jun 26EST
    		-$0.23---
    Mar 26
    Reported May 5
    		$0.17$0.05+240.00%Beat+750.0%
    Dec 25
    Reported Feb 3
    		$0.10$0.04+150.00%Beat+1100.0%
    Sep 25
    Reported Nov 4
    		$0.07$0.04+75.00%Beat+450.0%
    Jun 25
    Reported Sep 9
    		$-0.01$-0.01+24.81%Beat+0.0%
    Mar 25
    Reported May 6
    		$0.02$-0.01+300.00%Beat+150.0%
    Dec 24
    Reported Feb 4
    		$-0.01$-0.01+13.04%Beat-200.0%
    Sep 24
    Reported Nov 5
    		$-0.02$-0.01-100.00%Miss+75.0%
    Jun 24
    Reported Sep 10
    		$-0.01N/A+66.67%Beat+88.9%
    Mar 24
    Reported May 7
    		$-0.04$-0.03-33.33%Miss+20.0%
    Dec 23
    Reported Feb 6
    		$0.01$-0.02+150.00%Beat+114.3%
    Sep 23
    Reported Nov 7
    		$-0.08$-0.04-100.00%Miss-60.0%
    Jun 23
    Reported Sep 12
    		$-0.09$-0.04-125.00%Miss+0.0%
    Mar 23
    Reported May 9
    		$-0.05$-0.05+0.00%Beat-400.0%
    Dec 22
    Reported Feb 7
    		$-0.07$-0.09+22.22%Beat-275.0%
    Sep 22
    Reported Nov 8
    		$-0.05$-0.04-25.00%Miss-171.4%
    Jun 22
    Reported Sep 13
    		$-0.09$-0.03-200.00%Miss-280.0%
    Mar 22
    Reported May 10
    		$-0.01N/A-116.67%Miss-114.3%
    Dec 21
    Reported Feb 9
    		$0.04$0.07-42.86%Miss+110.8%
    Sep 21
    Reported Nov 9
    		$0.07$0.05+40.00%Beat-6.0%
    Jun 21
    Reported Sep 21
    		$0.05$0.06-16.67%Miss+132.3%
    Mar 21
    Reported May 10
    		$0.07$-0.07+200.00%Beat+1.0%
    Dec 20
    Reported Mar 5
    		$-0.37N/AN/ABeat-633.9%
    Sep 20
    Reported Dec 31
    		$0.07$0.00N/ABeat+109.2%
    Jun 20
    Reported Sep 30
    		$-0.15$0.00N/AMiss+76.5%
    Mar 20
    Reported Jun 29
    		$0.07$0.00N/ABeat+108.6%
    Dec 19
    Reported Mar 30
    		$0.07$0.00N/ABeat+108.6%
    Sep 19
    Reported Nov 14
    		$-0.81$-0.40-102.50%Miss+32.4%
    Jun 19
    Reported Aug 13
    		$-0.66$-0.30-120.00%Miss+29.9%
    Mar 19
    Reported May 15
    		$-0.81$-0.54-50.00%Miss+21.2%
    Dec 18
    Reported Mar 22
    		$-0.81$-0.54-50.00%Miss+21.2%
    Sep 18
    Reported Nov 14
    		$-1.20$0.00N/ABeat-38.9%
    Jun 18
    Reported Aug 14
    		$-0.94N/AN/ABeat-26.6%
    Mar 18
    Reported May 14
    		$-1.03$0.00N/ABeat+48.1%
    Dec 17
    Reported Mar 8
    		$-1.03$0.00N/ABeat+66.0%
    Sep 17
    Reported Nov 14
    		$-0.86N/AN/ABeat+80.5%
    Jun 17
    Reported Aug 14
    		$-0.74N/AN/ABeat-
    Mar 17
    Reported May 12
    		$-1.98N/AN/ABeat-
    Dec 16
    Reported Mar 6
    		$-3.02N/AN/ABeat-
    Sep 16
    Reported Nov 10
    		$-4.43N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio32.73EV/EBITDA162.02x
    Price/FCF34.73xFCF Yield2.88%
    Profitability
    Profit Margin-1.22%Operating Margin-11.50%
    ROE-5.88%ROIC-2.53%
    Financial Health
    Debt/Equity0.25xInterest Coverage-1.85x
    Current Ratio1.03xQuick Ratio1.03x
    Trading Statistics
    Beta0.40Avg Volume203.13K
    52-Week High$12.6452-Week Low$3.56

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$10.94
    SMA 20$10.85
    SMA 50$11.13
    SMA 200$8.14
    EMA 10$10.90
    EMA 20$10.93
    EMA 50$10.64
    EMA 200$8.47

    MACD

    Line: -0.02Signal: -0.01Hist: -0.01

    ADX

    ADX: 19.9+DI: 21.4-DI: 18.0

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down48.0
    PSAR$11.98

    Bollinger Bands

    Upper Band$11.33
    Lower Band$10.37
    %B Position880%(Upper)
    Band Width0.45

    RSI (14-Day)

    Neutral
    47.7

    Momentum Oscillators

    Stoch %K42.7
    Stoch %D45.9
    Williams %R-62.4
    ROC (10d)1.2%
    Momentum0.13
    CCI (20d)-44.1
    MFI (14d)47.2

    Volatility Measures

    ATR (14d)$0.51(4.7%)
    StdDev (20d)0.24
    Hist Vol37.4%(Moderate)

    Volume Flow

    VWAP$10.74
    OBV7.1M
    AD Line3.9M
    CMF (20d)-0.000

    Volume Metrics

    Avg Vol (20d)195.9K
    Vol Ratio1.3x
    VWMA (20d)$10.87

    Pivot Points

    R3$11.32
    R2$11.19
    R1$11.02
    Pivot Point$10.89
    S1$10.72
    S2$10.59
    S3$10.42

    Advanced Oscillators

    TSI-1.13
    Ultimate Osc40.1
    KST-47.73

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Revenue$251.94M$239.71M$236.10M$221.42M$218.14M$209.00M$205.14M$199.40M$193.07M$188.90M$182.49M$176.87M
    Cost of Revenue$77.68M$74.88M$75.89M$71.96M$69.50M$64.06M$63.39M$60.13M$59.08M$54.32M$55.25M$53.39M
    Gross Profit$174.27M$164.82M$160.22M$149.46M$148.64M$144.94M$141.75M$139.27M$133.99M$134.58M$127.23M$123.48M
    Operating Expenses$203.35M$151.56M$151.93M$151.62M$158.80M$157.49M$146.65M$144.15M$139.79M$136.36M$137.95M$134.43M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$76.53M$26.61M$30.27M$27.82M$38.60M$28.10M$27.54M$29.59M$27.55M$25.25M$28.95M$28.99M
    Operating Income$-29,079,000$13.26M$8.29M$-2,151,000$-10,158,000$-12,556,000$-4,896,000$-4,884,000$-5,793,000$-1,785,000$-10,718,000$-10,943,000
    Interest Income$-988,000$-1,246,000$-1,251,000$-2,842,000$-1,160,000$-744,000$-1,243,000$3.44M$-1,140,000$-2,817,000$-661,000$0
    Interest Expense$694,000$806,000$373,000$2.05M$903,000$901,000$410,000$0$615,000$1.94M$18,000$547,000
    Income Before Tax$-29,773,000$12.46M$7.92M$-4,203,000$-11,061,000$-13,457,000$-5,306,000$-947,000$-6,408,000$-3,728,000$-10,736,000$-11,490,000
    Income Tax Expense$167,000$651,000$247,000$806,000$72,000$34,000$404,000$1.31M$-224,000$93,000$226,000$506,000
    Net Income$-29,940,000$11.80M$7.67M$-5,009,000$-11,133,000$-13,491,000$-5,710,000$-2,254,000$-6,184,000$-3,821,000$-10,962,000$-11,996,000
    EBITDA$-23,834,000$18.77M$14.46M$2.16M$-4,408,000$-7,285,000$1.45M$1.05M$-99,000$3.49M$-5,699,000$-6,760,000
    EBIT$-28,785,000$13.70M$9.17M$-1,345,000$-9,901,000$-12,713,000$-4,063,000$-4,384,000$-5,268,000$-911,000$-10,075,000$-11,199,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about INNV

    News

    InnovAge Holding Corp. (INNV) Reports Next Week: Wall Street Expects Earnings Growth

    InnovAge Holding Corp. (INNV) is expected to report significant year-over-year earnings growth for the quarter ended June 2026, with Wall Street anticipating an 800% increase in EPS to $0.07 and a 7.7% rise in revenues to $238.35 million. The company's Zacks Earnings ESP of +22.73% combined with a Zacks Rank of #3 suggests a high probability of beating the consensus EPS estimate. Investors are advised to consider the company's Earnings ESP and Zacks Rank as indicators for potential stock movement following the earnings release on September 8.

    Yahoo Finance•9/1/26•
    Somewhat-Bullish

    Algert Global LLC Purchases 563,735 Shares of InnovAge Holding Corp. $INNV

    Algert Global LLC significantly increased its stake in InnovAge Holding Corp. (NASDAQ:INNV) during the second quarter, purchasing an additional 563,735 shares to bring its total holdings to 630,520 shares, valued at approximately $7.47 million. Other institutional investors like Bank of America, Goldman Sachs, and Jane Street also adjusted their positions. Despite this increased institutional interest, analyst sentiment remains cautious, with an average "Reduce" rating and a price target of $10.00 against the stock's opening price of $11.04.

    MarketBeat•8/27/26•
    Neutral

    InnovAge Announces Conference Call to Discuss Fourth Quarter and Fiscal 2026 Financial Results and Participation in Upcoming Wells Fargo Healthcare Conference

    InnovAge Holding Corp. (Nasdaq: INNV) will release its fiscal fourth quarter and full year 2026 financial results on Tuesday, September 8, 2026, after market close. The company will host a conference call at 5 p.m. E.T. to discuss these results. Additionally, InnovAge will participate in the upcoming Wells Fargo Healthcare Conference.

    Barchart.com•8/26/26•
    Neutral

    Welch Capital Partners LLC NY Makes New $1.62 Million Investment in InnovAge Holding Corp. $INNV

    Welch Capital Partners LLC NY has made a new investment of $1.62 million in InnovAge Holding Corp. (NASDAQ:INNV), acquiring 136,408 shares, which now represents 0.3% of their portfolio. Other institutional investors like Deutsche Bank, Bank of America, and JPMorgan Chase & Co. have also increased their stakes in InnovAge. Despite some institutional buying, analyst sentiment is cautious, with an average "Reduce" rating and a $10.00 price target, though KeyCorp recently upgraded the stock to "overweight" with a $13 target.

    MarketBeat•8/23/26•
    Somewhat-Bearish

    INNV: Operational Optimization And Margin Focus Will Shape Fairly Valued Outlook

    Analysts have increased their price target for InnovAge Holding (INNV) to $13, citing operational optimization, recent business momentum, and a focus on margin preservation. Despite being removed from several Russell Value Benchmark indices, the company's fair value has been significantly revised upwards from $7 to $10, reflecting a modestly higher projected revenue growth and a higher valuation multiple on earnings.

    Simply Wall Street•8/23/26•
    Bullish

    Frequently Asked Questions About INNV

    Does INNV pay dividends?
    InnovAge Holding Corp (INNV) does not currently pay a regular dividend.
    What is INNV's P/E ratio?
    InnovAge Holding Corp has a price-to-earnings (P/E) ratio of 32.73.
    What is INNV's market cap?
    InnovAge Holding Corp (INNV) has a market capitalization of $1.47B with a current stock price of $10.80.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In